Research and Markets has announced the addition of the "Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 4.1.2.30) - Pipeline Review, H2 2016" report to their offering.
Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 4.1.2.30) - Pipeline Review, H2 2016', provides in depth analysis on Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 4.1.2.30) targeted pipeline therapeutics.
The report provides comprehensive information on the Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 4.1.2.30), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved in Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 4.1.2.30) targeted therapeutics development and features dormant and discontinued projects.
Key Topics Covered:
- Introduction
- Steroid 17 Alpha Hydroxylase/17,20 Lyase Overview
- Therapeutics Development
- Pipeline Products for Steroid 17 Alpha Hydroxylase/17,20 Lyase - Overview
- Pipeline Products for Steroid 17 Alpha Hydroxylase/17,20 Lyase - Comparative Analysis
- Steroid 17 Alpha Hydroxylase/17,20 Lyase - Therapeutics under Development by Companies
- Steroid 17 Alpha Hydroxylase/17,20 Lyase - Therapeutics under Investigation by Universities/Institutes
- Steroid 17 Alpha Hydroxylase/17,20 Lyase Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Steroid 17 Alpha Hydroxylase/17,20 Lyase - Products under Development by Companies
- Steroid 17 Alpha Hydroxylase/17,20 Lyase - Products under Investigation by Universities/Institutes
- Steroid 17 Alpha Hydroxylase/17,20 Lyase - Companies Involved in Therapeutics Development
- Asana BioSciences LLC
- Johnson & Johnson
- Leon-Nanodrugs GmbH
- Millennium Pharmaceuticals Inc
- Tokai Pharmaceuticals Inc
For more information about this report visit http://www.researchandmarkets.com/research/r2wrl8/steroid_17_alpha
View source version on businesswire.com: http://www.businesswire.com/news/home/20170126005895/en/